1. Home
  2. CGTX vs MTEX Comparison

CGTX vs MTEX Comparison

Compare CGTX & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • MTEX
  • Stock Information
  • Founded
  • CGTX 2007
  • MTEX 1993
  • Country
  • CGTX United States
  • MTEX United States
  • Employees
  • CGTX N/A
  • MTEX N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • CGTX Health Care
  • MTEX Health Care
  • Exchange
  • CGTX Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • CGTX 20.5M
  • MTEX 20.0M
  • IPO Year
  • CGTX 2021
  • MTEX 1999
  • Fundamental
  • Price
  • CGTX $0.41
  • MTEX $9.20
  • Analyst Decision
  • CGTX Strong Buy
  • MTEX
  • Analyst Count
  • CGTX 5
  • MTEX 0
  • Target Price
  • CGTX $5.63
  • MTEX N/A
  • AVG Volume (30 Days)
  • CGTX 2.0M
  • MTEX 18.7K
  • Earning Date
  • CGTX 08-07-2025
  • MTEX 08-12-2025
  • Dividend Yield
  • CGTX N/A
  • MTEX N/A
  • EPS Growth
  • CGTX N/A
  • MTEX N/A
  • EPS
  • CGTX N/A
  • MTEX N/A
  • Revenue
  • CGTX N/A
  • MTEX $115,036,000.00
  • Revenue This Year
  • CGTX N/A
  • MTEX N/A
  • Revenue Next Year
  • CGTX N/A
  • MTEX N/A
  • P/E Ratio
  • CGTX N/A
  • MTEX N/A
  • Revenue Growth
  • CGTX N/A
  • MTEX N/A
  • 52 Week Low
  • CGTX $0.22
  • MTEX $6.75
  • 52 Week High
  • CGTX $2.54
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 67.18
  • MTEX 45.15
  • Support Level
  • CGTX $0.29
  • MTEX $8.81
  • Resistance Level
  • CGTX $0.34
  • MTEX $10.23
  • Average True Range (ATR)
  • CGTX 0.03
  • MTEX 0.68
  • MACD
  • CGTX 0.01
  • MTEX -0.02
  • Stochastic Oscillator
  • CGTX 92.43
  • MTEX 32.90

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: